NON-DISCLOSURE, NON-SOLICITATION AND NON-COMPETITION AGREEMENTNon-Disclosure, Non-Solicitation and Non-Competition Agreement • November 12th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
WHEREAS the Corporation is in the business of researching and developing novel pharmaceutical products that target the endocannabinoid system;
NON-DISCLOSURE, NON-SOLICITATION AND NON-COMPETITION AGREEMENTNon-Disclosure, Non-Solicitation and Non-Competition Agreement • November 12th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
AND WHEREAS the Corporation has agreed to retain the services of the Consultant pursuant to the terms of a consultant agreement between the Consultant and the Corporation dated as of the date hereof (the “Consulting Agreement”) and the Consultant has agreed to provide such services;
SHARE PURCHASE AGREEMENTShare Purchase Agreement • November 12th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
WHEREAS the Shareholders desire to sell to the Purchaser, and the Purchaser desires to purchase from the Shareholders, all of the issued and outstanding shares in the capital of the Corporation pursuant to the terms and conditions hereof.
CONSULTING AND ADVISORY AGREEMENTConsulting and Advisory Agreement • November 12th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations
This Agreement is made effective as of July 1, 2015, by and between CYNAPSUS Therapeutics Inc., a Canadian corporation with offices at 828 Richmond Street West, Toronto, Ontario, Canada M6J 1C9 (“CYNAPSUS”) and Hutchinson and Associates (“Consultant”) an Independent Consultant located at 399 Pineville Road, Newtown, PA 18940.
NON-DISCLOSURE, NON-SOLICITATION AND NON-COMPETITION AGREEMENTNon-Disclosure, Non-Solicitation and Non-Competition Agreement • November 12th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
WHEREAS the Corporation is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson’s disease;
SHARE PURCHASE AGREEMENT AMENDING AGREEMENTShare Purchase Agreement • November 12th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
WHEREAS the Purchaser, the Shareholders and the Corporation entered into a share purchase agreement dated as of December 22, 2011 (the “Share Purchase Agreement”), whereby the Shareholders agreed to sell to the Purchaser, and the Purchaser agreed to purchase from the Shareholders, all of the issued and outstanding shares in the capital of the Corporation;
